In 2012, Krakstad et al. found decreased GPER mRNA and protein levels and increased ERα levels in high grade endometrial carcinoma, supporting the association between GPER loss and disease progression from primary to metastatic lesions (119). Here, GPER1 is linked to endometrial carcinoma.